Terms: = Ovarian cancer AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB AND Diagnosis
68 results:
1. Successful Treatment of a Case of Crescentic Glomerulonephritis in a Patient with Primary Peritoneal Carcinoma: A case report.
Zribi A; Nagy A; Riyami MA; Burney IA
Sultan Qaboos Univ Med J; 2024 Feb; 24(1):119-122. PubMed ID: 38434475
[TBL] [Abstract] [Full Text] [Related]
2. Giant left pheochromocytoma with vascular anomalies and pelvic horseshoe kidney: a case report.
Biben E; Menon L; Gokden N; Spond MF; Eichhorn JM; Aydin AM
BMC Urol; 2023 Dec; 23(1):204. PubMed ID: 38066479
[TBL] [Abstract] [Full Text] [Related]
3. An Aptamer-Based Nanoflow Cytometry Method for the Molecular Detection and Classification of ovarian cancers through Profiling of Tumor Markers on Small Extracellular Vesicles.
Li J; Li Y; Li Q; Sun L; Tan Q; Zheng L; Lu Y; Zhu J; Qu F; Tan W
Angew Chem Int Ed Engl; 2024 Jan; 63(4):e202314262. PubMed ID: 38012811
[TBL] [Abstract] [Full Text] [Related]
4. Expression of egfr, PD-L1, and the mismatch repair proteins before and following therapy in malignant serous effusions with metastatic high-grade serous tubo-ovarian carcinoma.
Nikas IP; Park SY; Song MJ; Lee C; Ryu HS
Diagn Cytopathol; 2024 Feb; 52(2):69-75. PubMed ID: 37937321
[TBL] [Abstract] [Full Text] [Related]
5. Mass Spectrometry-Based Proteomics of Epithelial ovarian cancers: A Clinical Perspective.
Qian L; Sun R; Xue Z; Guo T
Mol Cell Proteomics; 2023 Jul; 22(7):100578. PubMed ID: 37209814
[TBL] [Abstract] [Full Text] [Related]
6. Advances in ovarian cancer Treatment Beyond PARP Inhibitors.
Aliyuda F; Moschetta M; Ghose A; Sofia Rallis K; Sheriff M; Sanchez E; Rassy E; Boussios S
Curr Cancer Drug Targets; 2023; 23(6):433-446. PubMed ID: 36757037
[TBL] [Abstract] [Full Text] [Related]
7. Identification of a novel peptide ligand for the cancer-specific receptor mutation egfrvIII using high-throughput sequencing of phage-selected peptides.
Mansour S; Adhya I; Lebleu C; Dumpati R; Rehan A; Chall S; Dai J; Errasti G; Delacroix T; Chakrabarti R
Sci Rep; 2022 Dec; 12(1):20725. PubMed ID: 36456600
[TBL] [Abstract] [Full Text] [Related]
8. COMMD3-Mediated Endosomal Trafficking of HER2 Inhibits the Progression of ovarian Carcinoma.
Wang S; Liu Y; Li S; Chen Y; Liu Y; Yan J; Wu J; Li J; Wang L; Xiang R; Shi Y; Qin X; Yang S
Mol Cancer Res; 2023 Mar; 21(3):199-213. PubMed ID: 36445330
[TBL] [Abstract] [Full Text] [Related]
9. Mutational spectrum of BRCA1/2 genes in Moroccan patients with hereditary breast and/or ovarian cancer, and review of BRCA mutations in the mena region.
Elalaoui SC; Laarabi FZ; Afif L; Lyahyai J; Ratbi I; Jaouad IC; Doubaj Y; Sahli M; Ouhenach M; Sefiani A
Breast Cancer Res Treat; 2022 Jul; 194(1):187-198. PubMed ID: 35578052
[TBL] [Abstract] [Full Text] [Related]
10. Recent advances in biosensor devices for HER-2 cancer biomarker detection.
Chupradit S; Jasim SA; Bokov D; Mahmoud MZ; Roomi AB; Hachem K; Rudiansyah M; Suksatan W; Bidares R
Anal Methods; 2022 Mar; 14(13):1301-1310. PubMed ID: 35318477
[TBL] [Abstract] [Full Text] [Related]
11. Survival and biomarker analysis for ovarian mucinous carcinoma according to invasive patterns: retrospective analysis and review literature.
Hada T; Miyamoto M; Ishibashi H; Matsuura H; Sakamoto T; Kakimoto S; Iwahashi H; Tsuda H; Takano M
J Ovarian Res; 2021 Feb; 14(1):33. PubMed ID: 33583413
[TBL] [Abstract] [Full Text] [Related]
12. Population-based estimates of survival among elderly patients with brain metastases.
Lamba N; Kearney RB; Catalano PJ; Hassett MJ; Wen PY; Haas-Kogan DA; Aizer AA
Neuro Oncol; 2021 Apr; 23(4):661-676. PubMed ID: 33068418
[TBL] [Abstract] [Full Text] [Related]
13. Circulating epithelial tumor cell analysis in CSF in patients with leptomeningeal metastases.
van Bussel MTJ; Pluim D; Milojkovic Kerklaan B; Bol M; Sikorska K; Linders DTC; van den Broek D; Beijnen JH; Schellens JHM; Brandsma D
Neurology; 2020 Feb; 94(5):e521-e528. PubMed ID: 31907288
[TBL] [Abstract] [Full Text] [Related]
14. Serum Human Epididymis Protein 4 is Associated with Renal Function and Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus.
Zhang M; Zhao B; Xie J; Liang Y; Yang Z
Biomed Res Int; 2019; 2019():4831459. PubMed ID: 31815140
[TBL] [Abstract] [Full Text] [Related]
15. ToleRability of BevacizUmab in elderly ovarian cancer patients (TURBO study): a case-control study of a real-life experience.
Amadio G; Marchetti C; Villani ER; Fusco D; Stollagli F; Bottoni C; Distefano M; Colloca G; Scambia G; Fagotti A
J Gynecol Oncol; 2020 Jan; 31(1):e6. PubMed ID: 31788996
[TBL] [Abstract] [Full Text] [Related]
16. Women With Synchronous or Metachronous Lung and ovarian cancer: A Multi-Institutional Report.
Mariniello A; Ghisoni E; Righi L; Catino A; Chiari R; Del Conte A; Barbieri F; Cecere F; Gelibter A; Giajlevra M; Parra HS; Zichi C; DI Maio M; Valabrega G; Novello S
In Vivo; 2019; 33(6):2021-2026. PubMed ID: 31662533
[TBL] [Abstract] [Full Text] [Related]
17. Circulating miRNA Profiling in Plasma Samples of ovarian cancer Patients.
Penyige A; Márton É; Soltész B; Szilágyi-Bónizs M; Póka R; Lukács J; Széles L; Nagy B
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540229
[TBL] [Abstract] [Full Text] [Related]
18. ALK rearrangement: a high-frequency alteration in ovarian metastasis from lung adenocarcinoma.
Bi R; Bai Q; Zhu X; Tu X; Cai X; Jiang W; Xu X; Tang S; Ge H; Chang B; Cheng Y; Gan H; Zhou X; Yang W
Diagn Pathol; 2019 Aug; 14(1):96. PubMed ID: 31455365
[TBL] [Abstract] [Full Text] [Related]
19. lncRNA MEG3 modified epithelial-mesenchymal transition of ovarian cancer cells by sponging miR-219a-5p and regulating egfr.
Wang L; Yu M; Zhao S
J Cell Biochem; 2019 Oct; 120(10):17709-17722. PubMed ID: 31161607
[TBL] [Abstract] [Full Text] [Related]
20. FAM83D promotes ovarian cancer progression and its potential application in diagnosis of invasive ovarian cancer.
Zhang Q; Yu S; Lok SIS; Wong AST; Jiao Y; Lee LTO
J Cell Mol Med; 2019 Jul; 23(7):4569-4581. PubMed ID: 31037837
[TBL] [Abstract] [Full Text] [Related]
[Next]
